Two phase 3 trials of Merck & Co's Keytruda in metastatic castration-resistant prostate cancer (CRPC) and advanced liver cancer have ended in failure, proving once again that cancer immunotherapy ...
Join your peeps for laughter, learning, and lobster rolls at B2B Forum! You'll grow your marketing and leadership skills, meet friends, and be inspired by new and different ideas. Right now, tickets ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results